IBL HealthCare Income Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	4,218	4,322	3,603	4,028	3,651	3,004
Revenue Growth (YoY)	13.34%	19.96%	-10.54%	10.32%	21.55%	12.73%
Cost of Revenue	2,647	2,879	2,654	2,691	2,400	1,985
Gross Profit	1,571	1,444	949.32	1,336	1,251	1,019
Selling, General & Admin	1,135	999.3	795.96	726.7	680.77	606.06
Other Operating Expenses	-17.62	-	-	-	-	-
Operating Expenses	1,117	999.3	795.96	726.7	680.77	612.19
Operating Income	453.84	444.59	153.35	609.68	570.69	406.77
Interest Expense	-46.25	-58.29	-65.43	-64.14	-25.7	-26.34
Interest & Investment Income	-	-	-	-	-	10.47
Currency Exchange Gain (Loss)	-8.56	-12.51	27.18	-109.57	-72.83	3.87
Other Non Operating Income (Expenses)	5.96	3.3	3.7	22.86	9.81	13.09
EBT Excluding Unusual Items	404.99	377.09	118.8	458.82	481.97	407.87
Gain (Loss) on Sale of Assets	-	-	-	0.01	1.92	-
Asset Writedown	-	-	-10.1	-	-0.62	-
Pretax Income	404.99	377.09	108.7	458.83	483.27	409.15
Income Tax Expense	191.05	168.72	101.15	149.87	180.41	108.66
Net Income	213.94	208.37	7.56	308.96	302.86	300.49
Net Income to Common	213.94	208.37	7.56	308.96	302.86	300.49
Net Income Growth	-	2658.05%	-97.56%	2.02%	0.79%	36.57%
Shares Outstanding (Basic)	99	99	99	99	99	99
Shares Outstanding (Diluted)	99	99	99	99	99	99
Shares Change (YoY)	-	-	-	-	0.00%	-0.00%
EPS (Basic)	2.17	2.11	0.08	3.14	3.07	3.05
EPS (Diluted)	2.17	2.11	0.08	3.14	3.07	3.05
EPS Growth	-	2658.06%	-97.56%	2.02%	0.79%	36.57%
Free Cash Flow	-22.73	-278.81	566.44	24.34	55.56	65.09
Free Cash Flow Per Share	-0.23	-2.83	5.75	0.25	0.56	0.66
Dividend Per Share	-	-	-	-	0.659	0.549
Dividend Growth	-	-	-	-	19.98%	-49.99%
Gross Margin	37.25%	33.40%	26.35%	33.18%	34.28%	33.92%
Operating Margin	10.76%	10.29%	4.26%	15.14%	15.63%	13.54%
Profit Margin	5.07%	4.82%	0.21%	7.67%	8.29%	10.00%
Free Cash Flow Margin	-0.54%	-6.45%	15.72%	0.60%	1.52%	2.17%
EBITDA	458.78	447.81	156.44	612.95	575.98	411.77
EBITDA Margin	10.88%	10.36%	4.34%	15.22%	15.78%	13.71%
D&A For EBITDA	4.94	3.22	3.09	3.28	5.29	5
EBIT	453.84	444.59	153.35	609.68	570.69	406.77
EBIT Margin	10.76%	10.29%	4.26%	15.14%	15.63%	13.54%
Effective Tax Rate	47.17%	44.74%	93.05%	32.66%	37.33%	26.56%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.